title: Uremic anorexia: a consequence of persistently high brain serotonin levels? The tryptophan/serotonin disorder hypothesis.
abstract: Anorexia is a frequent part of uremic syndrome, contributing to malnutrition in dialysis patients. Many factors have been suggested as responsible for uremic anorexia. In this paper we formulate a new hypothesis to explain the appetite disorders in dialysis patients: "the tryptophan/serotonin disorder hypothesis." We review current knowledge of normal hunger-satiety cycle control and the disorders described in uremic patients. There are four phases in food intake regulation: (1) the gastric phase, during which food induces satiety through gastric distention and satiety peptide release; (2) the post absorptive phase, during which circulating compounds, including glucose and amino acids, cause satiety by hepatic receptors via the vagus nerve; (3) the hepatic phase, during which adenosine triphosphate (ATP) concentration is the main stimulus inducing hunger or satiety, with cytokines inhibiting ATP production; and (4) the central phase, during which appetite is regulated through peripheral (circulating plasma substances and neurotransmitters) and brain stimuli. Brain serotonin is the final target for peripheral mechanisms controlling appetite. High brain serotonin levels and a lower serotonin/dopamine ratio cause anorexia. Plasma and brain amino acid concentrations are recognized factors involved in neurotransmitter synthesis and appetite control. Tryptophan is the substrate of serotonin synthesis. High plasma levels of anorectics such as tryptophan (plasma and brain), cholecystokinin, tumor necrosis factor alpha, interleukin-1, and leptin, and deficiencies of nitric oxide and neuropeptide Y have been described in uremia; all increase intracerebral serotonin. We suggest that brain serotonin hyperproduction due to a uremic-dependent excess of tryptophan may be the final common pathway involved in the genesis of uremic anorexia. Various methods of ameliorating anorexia by decreasing the central effects of serotonin are proposed.
authors.affiliation: Laboratorio de Gastroenterologia, Hospital Universitario de la Princesa, Madrid, Spain.
authors.forename: A
authors.initials: A
authors.lastname: Aguilera
authors.forename: R
authors.initials: R
authors.lastname: Selgas
authors.forename: R
authors.initials: R
authors.lastname: Codoceo
authors.forename: A
authors.initials: A
authors.lastname: Bajo
mesh_terms: D000596:Amino Acids / Q000378:metabolism; D000855:Anorexia / Q000209:etiology*; D001921:Brain / Q000378:metabolism*; D016207:Cytokines / Q000502:physiology; D004435:Eating; D006801:Humans; D006815:Hunger; D020738:Leptin / Q000502:physiology; D010455:Peptides / Q000502:physiology; D012528:Satiety Response; D012701:Serotonin / Q000378:metabolism*; D014364:Tryptophan / Q000378:metabolism*; D014511:Uremia / Q000150:complications*
chemical_list: D000596:Amino Acids; D016207:Cytokines; D020738:Leptin; D010455:Peptides; D012701:Serotonin; D014364:Tryptophan